Loading...
•
Mar 31
XpresSpa Q1 2025 Earnings Report
XWELL, Inc. reported its financial results for the first quarter of 2025, showing a decrease in total revenue and a net loss, while continuing strategic initiatives and facing Nasdaq listing compliance challenges.
Key Takeaways
XWELL, Inc. experienced a decrease in total revenue to $7,023,000 in Q1 2025, down 20% from the previous year, primarily due to lower CDC XpresTest revenue. The company reported a net loss of $4,588,000 and an EPS of -$1.00. Despite these challenges, XWELL is focusing on strategic partnerships and cost reductions to improve liquidity and profitability.
Total revenue decreased by 20% to $7,023,000 in Q1 2025, primarily driven by lower CDC XpresTest revenue.
The company reported a net loss of $4,588,000 and a basic and diluted loss per share of -$1.00.
XWELL is actively implementing cost reduction efforts, capital spending controls, and exploring additional financing options to improve liquidity.
The company received a Nasdaq non-compliance letter regarding its minimum bid price and is working to regain compliance by November 10, 2025.
XpresSpa
XpresSpa
XpresSpa Revenue by Segment
Revenue by Segment
XpresSpa Revenue
CapyFin.comNaples Wax Center Revenue
CapyFin.com Forward Guidance
XWELL, Inc. is focused on improving its financial position through strategic initiatives, cost reductions, and exploring additional financing options, while also addressing Nasdaq listing compliance.
Positive Outlook
- Aggressively pursuing strategic partnerships to strengthen long-term profitability.
- Implementing cost reduction efforts to improve overall cash position.
- Streamlining operations to enhance efficiency.
- Exploring additional financing options to fund future operations.
- XpresTest contract extended through a three-year contract with a total base value of $22.2 million.
Challenges Ahead
- Substantial doubt about the company's ability to continue as a going concern due to recurring losses and negative cash flows.
- Insufficient liquidity to fund future operations for at least the next 12 months.
- Uncertainty about raising sufficient additional equity or debt capital.
- Risk of delisting from Nasdaq due to not meeting the minimum bid price requirement.
- Potential for delay, reduction, or elimination of certain operations, or sale/merger of assets if capital is not raised.
Revenue & Expenses
Visualization of income flow from segment revenue to net income